PHARMACEUTICAL COMPOSITION CONTAINING ALIMAMAZINE TARTRATE Russian patent published in 2018 - IPC A61K31/5415 A61K47/38 A61K47/12 A61K47/04 A61K9/30 A61K9/22 A61P25/18 A61P25/00

Abstract RU 2659200 C1

FIELD: pharmaceutics.

SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine. Pharmaceutical composition contains alimamazine tartrate and auxiliary components. As auxiliary components, microcrystalline cellulose, hypromellose, silica colloidal dioxide and magnesium stearate in the amounts indicated in the claims are selected. Pharmaceutical composition of alimamazine tartrate is in the form of a tablet coated with a film coating.

EFFECT: tablet according to invention provides a sustained release of alimamazine tartrate, while retaining advantages in the form of a short half-life; characterized by satisfactory stability, strength of more than 70 N, and an abrasion resistance of at least 98,5%.

5 cl, 4 tbl, 5 ex

Similar patents RU2659200C1

Title	Year	Author	Number
PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS	2009	Morozova Margarita Alekseevna Beniashvili Allan Gerovich	RU2424807C2
ANXIOLYTIC, SEDATIVE AND ANTI-STRESS MEDICINAL PRODUCT AND METHOD OF ITS OBTAINING	2023	Rozhdestvenskij Aleksandr Viktorovich	RU2814110C1
PHARMACEUTICAL COMPOSITION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS	2009	Morozova Margarita Alekseevna Beniashvili Allan Gerovich	RU2384336C1
RETARD TABLETS OF TRIMEBUTINE	2013	Morozova Margarita Alekseevna Beniashvili Allan Gerovich	RU2536254C1
PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, AND ALSO A DOSAGE FORM BASED ON SPECIFIED PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, METHOD OF ITS OBTAINING AND USE OF DOSAGE FORM BASED ON PHARMACEUTICAL CEUTIC COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE	2020	Iksanov Rustam Munirovich Litvinova Elena Yurevna Lejkin Zakhar Naumovich Kuznetsova Irina Gennadevna Salakhetdinov Damir Khizbullaevich Rogozhkina Elena Alekseevna	RU2810575C1
CONTROLLED-RELEASE PHARMACEUTICAL PROXODOLOL COMPOSITION	2007	Juzhakov Sergej Danilovich Glushkov Robert Georgievich Chistjakov Viktor Vladimirovich Aristovskaja Natal'Ja Vjacheslavovna	RU2356532C2
PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	2021	Iksanov Rustam Munirovich Litvinova Elena Yurevna Lejkin Zakhar Naumovich Kuznetsova Irina Gennadevna Salakhetdinov Damir Khizballaevich Rogozhkina Elena Alekseevna	RU2818092C1
PHARMACEUTICAL COMPOSITION FOR TREATING HIV-INFECTION, METHOD FOR PREPARING AND METHOD OF USING	2013	Batjunin Gennadij Andreevich Malykh Natal'Ja Jur'Evna Punija Vikram Singkh	RU2543322C1
TABLET QUETIAPINE WITH PROLONGED RELEASE AND SYNTHESIS METHOD THEREOF	2015	Syrov Kirill Konstantinovich Nesteruk Vladimir Viktorovich	RU2588840C1
PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION	2009	Morozova Margarita Alekseevna Beniashvili Allan Gerovich	RU2414903C1

RU 2 659 200 C1

Authors

Syrov Kirill Konstantinovich

Nesteruk Vladimir Viktorovich

Dates

2018-06-28—Published

2017-07-24—Filed